Hybrid quantum mechanical/molecular mechanical molecular dynamics simulations of HIV-1 integrase/inhibitor complexes.
Human immunodeficiency virus (HIV)-1 integrase (IN) is an attractive target for development of acquired immunodeficiency syndrome chemotherapy. In this study, conventional and coupled quantum mechanical and molecular mechanical (QM/MM) molecular dynamics (MD) simulations of HIV-1 IN complexed with 5CITEP (IN-5CITEP) were carried out. In addition to differences in the bound position of 5CITEP, significant differences at the two levels of theory were observed in the metal coordination geometry and the areas involving residues 116-119 and 140-166. In the conventional MD simulation, the coordination of Mg(2+) was found to be a near-perfect octahedral geometry whereas a distorted octahedral complex was observed in QM/MM. All of the above reasons lead to a different pattern of protein-ligand salt link formation that was not observed in the classical MD simulation. Furthermore to provide a theoretical understanding of inhibition mechanisms of 5CITEP and its derivative (DKA), hybrid QM/MM MD simulations of the two complexes (IN-5CITEP and IN-DKA) have been performed. The results reveal that areas involving residues 60-68, 116-119, and 140-149 were substantially different among the two systems. The two systems show similar pattern of metal coordination geometry, i.e., a distorted octahedron. In IN-DKA, both OD1 and OD2 of Asp-64 coordinate the Mg(2+) in a monodentate fashion whereas only OD1 is chelated to the metal as observed in IN-5CITEP. The high potency of DKA as compared to 5CITEP is supported by a strong salt link formed between its carboxylate moiety and the ammonium group of Lys-159. Detailed comparisons between HIV-1 IN complexed with DKA and with 5CITEP provide information about ligand structure effects on protein-ligand interactions in particular with the Lys-159. This is useful for the design of new selective HIV-1 IN inhibitors.
Nunthaboot
Nadtanet
N
Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
Pianwanit
Somsak
S
Parasuk
Vudhichai
V
Ebalunode
Jerry O
JO
Briggs
James M
JM
Kokpol
Sirirat
S
D002264:Carboxylic Acids / Q000737:chemistry; D003198:Computer Simulation; D019427:HIV Integrase / Q000737:chemistry*; D019428:HIV Integrase Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008024:Ligands; D008239:Lysine / Q000737:chemistry; D008274:Magnesium / Q000737:chemistry; D008956:Models, Chemical; D008958:Models, Molecular; D008968:Molecular Conformation; D011487:Protein Conformation; D011506:Proteins / Q000737:chemistry; D011789:Quantum Theory; D012492:Salts / Q000737:chemistry; D014867:Water / Q000737:chemistry
D002264:Carboxylic Acids; D019428:HIV Integrase Inhibitors; D008024:Ligands; D011506:Proteins; D012492:Salts; D014867:Water; D019427:HIV Integrase; D008274:Magnesium; D008239:Lysine; C514801:p31 integrase protein, Human immunodeficiency virus 1
J Med Chem. 2005 Mar 24;48(6):1930-40
15771437
J Med Chem. 2005 Jan 13;48(1):111-20
15634005
J Mol Graph Model. 2007 Jul;26(1):1-13
17046299
Biophys J. 2005 May;88(5):3072-82
15764656
Bioorg Med Chem Lett. 2004 Mar 22;14(6):1447-54
15006380
J Med Chem. 2004 Apr 8;47(8):1879-81
15055986
J Mol Biol. 1989 Jul 5;208(1):159-81
2769750
Nat Rev Drug Discov. 2005 Mar;4(3):236-48
15729361
J Med Chem. 2005 Dec 15;48(25):8009-15
16335925
J Med Chem. 2004 Dec 30;47(27):6673-80
15615516
J Med Chem. 2005 Jul 14;48(14):4526-34
15999991
J Med Chem. 2004 May 6;47(10):2561-73
15115398
Bioorg Med Chem. 2004 Dec 15;12(24):6371-81
15556755
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9150-4
9689049
Bioorg Med Chem Lett. 2006 Apr 1;16(7):1920-3
16439124
J Med Chem. 2001 Sep 13;44(19):3043-7
11543671
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10080-5
16785440
Mol Pharmacol. 2003 Sep;64(3):600-9
12920196
Bioorg Med Chem. 2006 Jul 1;14(13):4552-67
16524737
J Am Chem Soc. 2005 Mar 30;127(12):4454-65
15783228
Curr Top Med Chem. 2004;4(9):965-77
15134551
J Am Chem Soc. 2001 Dec 19;123(50):12708-9
11741448
J Med Chem. 2006 Jul 13;49(14):4248-60
16821784
Biophys J. 2003 Mar;84(3):1450-63
12609852
Biophys J. 2005 May;88(5):3133-46
15731379
J Med Chem. 2006 Mar 23;49(6):1939-45
16539381
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
8744570
J Phys Chem B. 1998 Apr 30;102(18):3586-616
24889800
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13040-3
10557269
J Phys Chem B. 2005 Aug 18;109(32):15645-50
16852982
Bioorg Med Chem. 2006 Dec 15;14(24):8420-9
17005407
J Med Chem. 2007 Mar 22;50(6):1133-45
17302399
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8458-62
3866234
J Med Chem. 2004 Oct 21;47(22):5583-6
15481994
J Med Chem. 2004 Oct 7;47(21):5298-310
15456274
Proteins. 2005 Jun 1;59(4):723-41
15815973
Bioorg Med Chem. 2007 Feb 1;15(3):1212-28
17158051
Proteins. 2003 Feb 15;50(3):451-63
12557187
J Biol Chem. 1997 Jul 18;272(29):18161-8
9218451
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6661-6
11997448
Biophys J. 1999 Jun;76(6):2999-3011
10354426
J Med Chem. 2005 Nov 3;48(22):7084-8
16250669